HIMS
Hims & Hers Health, Inc.
There isn't enough reported data to score HIMS yet.
V
Visa Inc.
V's fundamentals are strong: revenue grew 15% and earnings per share grew 21%. At 34x earnings, it's trading in line with its usual 33x. Analysts expect earnings growth.
HIMS Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Weak | |
| Stable | |
| Strong |
HIMS's revenue and balance sheet are currently strong, and its cash flow is stable, but its profitability is weak.
V Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
V's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like V.
HIMS PE Valuation
HIMS has no meaningful PE right now: it lost money over the past year.
V PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 28x | $420 | — |
| Cheap | 30x | $371 | -12% |
| Fair | 33x | $402 | -4.4% |
| Current | 34x | $420 | — |
| Expensive | 38x | $474 | +13% |
Historical ranges are pointers, not guarantees.
V's PE is in its fair range at 34x. If earnings grow as analysts expect, today's price would be 28x next year's earnings, in its cheap range.
HIMS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Turning to a loss | |
| Strong growth | |
| Stable | |
| Limited | |
| Low |
Analysts expect HIMS's revenue to grow, but its earnings to decline. However, they disagree widely on these estimates.
V Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Improving | |
| Moderate | |
| High |
V has the edge over HIMS on the outlook, with more favorable earnings and profitability expectations.
HIMS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.83 | -257% |
| Q2 2026 | -$0.63 | -180% |
| Q1 2026 | -$0.09 | -113% |
| Q4 2025 | $0.51 | -3.8% |
| Q3 2025 | $0.53 | +20% |
| Q2 2025 | $0.79 | +888% |
| Q1 2025 | $0.68 | +$0.69 |
| Q4 2024 | $0.53 | +$0.64 |
HIMS has swung to a loss: it lost $0.83 per share over the past year, after a profit the year before.
V Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $15.01 | +22% |
| Q3 2026 | $12.32 | +21% |
| Q2 2026 | $11.76 | +15% |
| Q1 2026 | $11.48 | +15% |
| Q4 2025 | $10.66 | +7.5% |
| Q3 2025 | $10.21 | +4.9% |
| Q2 2025 | $10.24 | +9.5% |
| Q1 2025 | $9.95 | +11% |
| Q4 2024 | $9.92 | +14% |
V has the edge over HIMS on earnings quality, reporting a profit while its opponent remains loss making.
HIMS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $890.4M | +49% |
| Q2 2026 | $753.2M | +38% |
| Q1 2026 | $608.1M | +3.8% |
| Q4 2025 | $617.8M | +28% |
| Q3 2025 | $599M | +49% |
| Q2 2025 | $544.8M | +73% |
| Q1 2025 | $586M | +111% |
| Q4 2024 | $481.1M | +95% |
HIMS has the edge over V on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -7.4% | -9.4 points |
| Q2 2026 | -13% | -18 points |
| Q1 2026 | -13% | -23 points |
| Q4 2025 | 1.5% | -2.4 points |
| Q3 2025 | 2% | -3.6 points |
| Q2 2025 | 4.9% | +1.4 points |
| Q1 2025 | 9.9% | +6.3 points |
| Q4 2024 | 3.9% | +4 points |
HIMS's operating margin was −7.4% last quarter, down 9.4 points from the same quarter a year ago.
V Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $12.1B | +13% |
| Q2 2026 | $11.6B | +14% |
| Q1 2026 | $11.2B | +17% |
| Q4 2025 | $10.9B | +15% |
| Q3 2025 | $10.7B | +12% |
| Q2 2025 | $10.2B | +14% |
| Q1 2025 | $9.6B | +9.3% |
| Q4 2024 | $9.5B | +10% |
V's revenue has grown year over year for 22 quarters in a row: $12.1B last quarter, up 13% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 60% | +2.5 points |
| Q2 2026 | 59% | -1.6 points |
| Q1 2026 | 64% | +7.8 points |
| Q4 2025 | 62% | -3.8 points |
| Q3 2025 | 57% | -8.7 points |
| Q2 2025 | 61% | -6 points |
| Q1 2025 | 57% | -4.4 points |
| Q4 2024 | 66% | -3.4 points |
V has the edge over HIMS on profitability, with a higher operating margin.
HIMS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $26M | -67% |
| Q2 2026 | -$68.2M | +$1.3M |
| Q1 2026 | $53.1M | +5.9% |
| Q3 2025 | $79.3M | -7% |
| Q2 2025 | -$69.5M | -230% |
| Q1 2025 | $50.1M | +94% |
| Q3 2024 | $85.3M | +238% |
| Q2 2024 | $53.6M | +219% |
HIMS has the edge over V on cash flow, with more consistent year-over-year improvement.
V Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $6.9B | +18% |
| Q2 2026 | $6.1B | -2.7% |
| Q1 2026 | $2.6B | -40% |
| Q4 2025 | $6.4B | +27% |
| Q3 2025 | $5.8B | -8% |
| Q2 2025 | $6.3B | +33% |
| Q1 2025 | $4.4B | +2.6% |
| Q4 2024 | $5.1B | +51% |
V's free cash flow was $22.1B over the past year, up 2.2% from the year before. Free cash flow isn't a meaningful measure for financial services companies like V.
HIMS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.9% | +2.1M shares |
| 1 year | -6% | -14.9M shares |
| 3 years | +11% | +23.7M shares |
| 5 years | +17% | +33.8M shares |
HIMS has 234M diluted shares, down 6% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2025 | $80.5M |
| Q3 2025 | $9.5M |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | $5M |
| Q3 2024 | $30M |
| Q2 2024 | $19.9M |
| Q1 2024 | $28.1M |
V Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -7% | -136M shares |
| 1 year | -7.6% | -148M shares |
| 3 years | -13% | -268M shares |
| 5 years | -17% | -378M shares |
| Available history | -20% | -443M shares |
V has the edge over HIMS on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $4B |
| Q2 2026 | $4.8B |
| Q1 2026 | $7.9B |
| Q4 2025 | $3.7B |
| Q3 2025 | $4.9B |
| Q2 2025 | $4.8B |
| Q1 2025 | $4.6B |
| Q4 2024 | $4B |
V spent $20.5B buying back its own shares over the past year, up 12% from the year before.
HIMS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2026 | -5.9x | Net Cash |
| Q4 2025 | -1.4x | Net Cash |
| Q3 2025 | -2.2x | Net Cash |
| Q2 2025 | -7.3x | Net Cash |
| Q1 2025 | -2.1x | Net Cash |
| Q4 2024 | -2.8x | Net Cash |
| Q3 2024 | -2.9x | Net Cash |
| Q2 2024 | -5.5x | Net Cash |
HIMS has more cash than debt.
V Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.3x | Very low |
| Q2 2026 | 0.4x | Very low |
| Q1 2026 | 0.4x | Very low |
| Q4 2025 | 0.2x | Very low |
| Q3 2025 | 0.3x | Very low |
| Q2 2025 | 0.3x | Very low |
| Q1 2025 | 0.4x | Very low |
| Q4 2024 | 0.3x | Very low |
V's net debt is less than a year of its operating earnings (EBITDA). Net leverage isn't a meaningful measure for financial services companies like V.
HIMS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 36.0 | Neutral |
| Stochastic | 23.0 | Neutral |
HIMS's weekly RSI is 36 (neutral) and its Stochastic is 23 (neutral).
V Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 73.7 | Overbought |
| Stochastic | 82.0 | Overbought |
V's weekly RSI is 74 (overbought) and its Stochastic is 82 (overbought).
HIMS PE vs Healthcare Sector
| Metric | HIMS | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 26x | — |
HIMS has no meaningful PE right now: it lost money over the past year.
V PE vs Financial Services Sector
| Metric | V | Sector median | Relative |
|---|---|---|---|
| PE | 34x | 13x | 162% above |
| PE % | 62 | 63 | 1 pt below |
V is trading at 34x earnings, a 162% premium to the Financial Services sector's median of 13x.
HIMS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $27.3 | 28% below |
| 20 week MA | $29.2 | 32% below |
| 50 week MA | $27.7 | 29% below |
| 100 week MA | $35.9 | 45% below |
| 200 week MA | $24.4 | 19% below |
HIMS is in a downtrend: it's below all five of its weekly moving averages, and 19% below its 200-week average.
V Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $397.6 | 5.7% above |
| 20 week MA | $378.3 | 11% above |
| 50 week MA | $346.0 | 21% above |
| 100 week MA | $343.7 | 22% above |
| 200 week MA | $300.6 | 40% above |
V has the edge over HIMS on trend strength, trading above more of its moving averages.
HIMS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.89 | $15.0 | +51% |
| 2021 | $15.0 | $6.65 | -56% |
| 2022 | $6.65 | $6.43 | -3.3% |
| 2023 | $6.43 | $8.90 | +38% |
| 2024 | $8.90 | $26.6 | +198% |
| 2025 | $26.6 | $34.3 | +29% |
| 2026 YTD | $34.3 | $19.7 | -42% |
HIMS's yearly returns have swung widely, from +198% in 2024 to −56% in 2021. It's down 42% so far in 2026.
V Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $189.4 | $208.7 | +10% |
| 2021 | $208.7 | $216.6 | +3.8% |
| 2022 | $216.6 | $205.8 | -5% |
| 2023 | $205.8 | $260.4 | +26% |
| 2024 | $260.4 | $318.7 | +22% |
| 2025 | $318.7 | $355.0 | +11% |
| 2026 YTD | $355.0 | $420.3 | +18% |
V has the edge over HIMS on returns for 2026, with the stronger performance.